about
Patient-reported outcomes in left ventricular assist device therapy: a systematic review and recommendations for clinical research and practice18F-FDG PET/CT in the diagnosis and management of continuous flow left ventricular assist device infections: A Case Series and Review of the Literature.No relationship between left ventricular radial wall motion and longitudinal velocity and the extent and severity of noncompaction cardiomyopathy.Microcirculatory assessment of patients under VA-ECMO.Tuberculous pericardial abscess causing right ventricular obstructionAlterations in aortic elasticity in noncompaction cardiomyopathy.CD16+ Monocytes and Skewed Macrophage Polarization toward M2 Type Hallmark Heart Transplant Acute Cellular Rejection.Evaluation of left atrial systolic function in noncompaction cardiomyopathy by real-time three-dimensional echocardiographyCardiac allograft vasculopathy in Dutch heart transplant recipients.Toxoplasma gondii serostatus is not associated with impaired long-term survival after heart transplantation.Preventing LVAD implantation by early short-term mechanical support and prolonged inodilator therapy : A case series with acute refractory cardiogenic shock treated with veno-arterial extracorporeal membrane oxygenation and optimised medical strategUnexpected finding in an adult with ventricular fibrillation and an accessory pathway: non-compaction cardiomyopathy.Remote monitoring of heart failure: benefits for therapeutic decision making.Chronic norovirus infection among solid organ recipients in a tertiary care hospital, the Netherlands, 2006-2014.Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.Early rapidly developing constrictive pericarditis after aortic valve surgery.Mismatch between the origin of premature ventricular complexes and the noncompacted myocardium in patients with noncompaction cardiomyopathy patients: involvement of the conduction system?Diagnostic uncertainties and future perspectives in noncompaction cardiomyopathy.Acute Kidney Injury as a Complication of Cardiac Transplantation: Incidence, Risk Factors, and Impact on 1-year Mortality and Renal Function.Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II.Thymus-Derived Regulatory T Cells Infiltrate the Cardiac Allograft Before Rejection.Löffler endocarditis: a rare cause of acute cardiac failure.Improved long-term survival in Dutch heart transplant patients despite increasing donor age: the Rotterdam experience.First direct human evidence of a probable implantable cardioverter-defibrillator lead-related scar serving as a substrate for ventricular tachycardia.Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction.Noncompaction cardiomyopathy, a frequently overlooked entity (…but beware of over diagnosis!).Kinking, thrombosis and need for re-operation in a patient with a left ventricular assist device.In search of an efficient strategy to monitor disease status of chronic heart failure outpatients: added value of blood biomarkers to clinical assessment.Paradoxical contributions of non-compacted and compacted segments to global left ventricular dysfunction in isolated left ventricular noncompaction.Psychological distress in patients with a left ventricular assist device and their partners: an exploratory study.Long-term follow-up of prophylactic implantable cardioverter-defibrillator-only therapy: comparison of ischemic and nonischemic heart disease.A comparison of the health status and psychological distress of partners of patients with a left ventricular assist device versus an implantable cardioverter defibrillator: a preliminary study.Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathy.Peripheral venoarterial extracorporeal life support despite impending left ventricular thrombosis: a bridge to resolution.Functional evaluation of sublingual microcirculation indicates successful weaning from VA-ECMO in cardiogenic shock.Acquired coagulopathy in patients with Left Ventricular Assist Devices.Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study.Acute kidney injury and 1-year mortality after left ventricular assist device implantation.Real-Life Use of Neurohormonal Antagonists and Loop Diuretics in Chronic Heart Failure: Analysis of Serial Biomarker Measurements and Clinical Outcome.Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation.
P50
Q26822021-F9F9A667-1C21-44B3-937F-3B187DA16AF2Q30490953-B51ED41D-FD21-4719-A583-7D087F33CC45Q30513997-5B9D1477-3582-4733-B13D-1B3B5BF19C95Q30826381-92367177-392F-4753-BFEC-4AF4D221FCF3Q35582887-150C1FD5-3048-4DB1-9778-DB9F1623A88EQ36237812-9D697253-981D-4C81-BD0D-01E6486BAE5CQ36341489-4C0F5F29-33DA-46EF-BAE6-5D56F7CEFB2AQ36444807-63946352-E389-42C5-83CB-FF569151C749Q37430110-76BBDF20-87BC-457F-98CD-9679C8798635Q37464884-A32B2F8D-FDDB-4800-BA2B-5E739D12DAB3Q37638446-6A610DC2-0637-4E8B-9AEC-0168FB5B8377Q37638468-E9F17A97-1FF2-4BD3-93B3-82725DC3021AQ38705567-CEC99EC8-A9D5-46A4-863A-79EC1A74A99EQ39077046-8B1F7403-70B5-45C6-89D0-E92A79802895Q39283980-C7686D4B-2DFA-4ADD-BD00-A3F814C80C12Q39438900-BA683B71-2FA6-46A9-AF5E-7DC9A9146F5FQ39446162-33C9AC32-5201-489F-BB06-D99046D058B5Q39453560-1D5F0571-7827-4520-A9C2-36C04DA2192FQ40417670-78003F00-DCDD-4481-8DFE-619767C0C74BQ40862992-E4663F8C-75EF-4DD5-8A99-8886E8DEDF5BQ41051962-2C5CB65D-EC4B-4BD2-85DE-18F3056B1F09Q41339600-C443B844-036D-4A10-87AC-34906AB48AD6Q41715459-F54773D2-0EFB-4D68-B2B1-079B1A75DFD8Q41846046-AA62BFEB-F286-4D55-BCC8-544A7FF9EEF3Q41868624-A3C97FCB-2BDA-4C5D-BA39-CAA1E511D3AAQ42324704-D10F351B-650B-4CC0-A5AF-8425C7E36939Q42369654-1EF37C19-2065-4BA9-8F5E-D225286BBA46Q42646632-9B2C4D1E-68B5-438E-8623-00692BB63894Q43487934-5DEC83B1-0B48-4DD3-BD46-2B7F7943800AQ44489481-CE525FDA-FB90-412E-B2F5-CBF32512F3FAQ44659018-C54502C5-DE94-410C-8683-A67D320ABE1EQ45066574-2C0C2585-7C51-427D-A516-17BCA2D65582Q45854608-585C536A-3C58-431F-8B52-52B7C984840FQ45935101-4D3E2BE0-CBE5-4EC1-816E-639A78DABEA3Q47162974-8E8118A7-2A14-4360-9E13-39A76D26BD52Q47222571-AFB6ABD2-9886-4F30-88E5-5F32E9FC4E1DQ47297971-2DC89340-E9CE-4FFE-B765-51339B6A06C8Q47315410-E7F42C11-138C-430F-8BFB-058516434D19Q47438578-EC638D6E-D242-40AD-82D6-617670BA7D8DQ47439735-CF728045-2F4E-4688-8443-574D787868DE
P50
description
cardioloog
@nl
in den Niederlanden praktizierender Kardiologe
@de
researcher ORCID ID = 0000-0002-3293-9261
@en
name
Kadir Caliskan
@ast
Kadir Caliskan
@de
Kadir Caliskan
@en
Kadir Caliskan
@es
Kadir Caliskan
@fr
Kadir Caliskan
@nl
type
label
Kadir Caliskan
@ast
Kadir Caliskan
@de
Kadir Caliskan
@en
Kadir Caliskan
@es
Kadir Caliskan
@fr
Kadir Caliskan
@nl
prefLabel
Kadir Caliskan
@ast
Kadir Caliskan
@de
Kadir Caliskan
@en
Kadir Caliskan
@es
Kadir Caliskan
@fr
Kadir Caliskan
@nl
P1006
P214
P1006
P106
P108
P1153
16548832800
P21
P214
P31
P3835
kadir-caliskan
P496
0000-0002-3293-9261
P569
1967-01-01T00:00:00Z
P735
P7859
viaf-286374611